Pregnant women eating eggs and peanuts to reduce baby food allergies (PrEggNut Study).
Not Applicable
Active, not recruiting
- Conditions
- Food AllergyInflammatory and Immune System - Allergies
- Registration Number
- ACTRN12618000937213
- Lead Sponsor
- Telethon Kids Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- Female
- Target Recruitment
- 2136
Inclusion Criteria
Women who are able to give informed consent, with a singleton pregnancy of less than 23 weeks gestation and who are planning to breastfeed for at least 4 months. Fetus to have at least two family members (mother, father or siblings) with medically diagnosed allergic disease (asthma, eczema, hay-fever or IgE mediated food allergy).
Exclusion Criteria
Women with egg or peanut allergies (<1% of adult population) will be excluded, as they would be unable to safely follow the intervention without an allergic reaction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does maternal egg and peanut consumption in ACTRN12618000937213 modulate immune tolerance mechanisms to prevent infant food allergies?
What is the comparative effectiveness of maternal egg and peanut intake in ACTRN12618000937213 versus standard allergen avoidance for infant allergy prevention?
Which biomarkers in ACTRN12618000937213 predict response to maternal dietary intervention with eggs and peanuts for food allergy reduction?
What adverse events are associated with maternal egg and peanut consumption in ACTRN12618000937213, and how are they managed during pregnancy?
Are there combination strategies with maternal egg/peanut intake in ACTRN12618000937213 and other immunomodulators that enhance allergy prevention?